Crowdonomics
WatchlistPortfolio
All companies
Pluton Biosciences, Inc. logo

Pluton Biosciences, Inc.

Operating

Biotech · St. Louis, MO

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$24,360,039
Crowd $98K · Private $24.3M · 4 rounds since 2019

Financials

FY2016–FY2020 (no data for FY2018) · from SEC filings · hover any figure for its source
$0
2016
$0
−$113K
2017
2018no data
$19K
−$389
2019
$477K
−$980K
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2016 reviewed*
FY2017 reviewed*
FY2019
FY2020
Income statement
Revenue
$0
$0
$19,431
$476,675
Cost of goods sold
$0
$0
$6,627
$188,857
Gross margin
—
—
66%
60%
Net income
$0
-$113,179
-$389
-$979,712
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$46,404
$14,567
$191,989
Accounts receivable
$0
$0
$22,785
$53,280
Total assets
$0
$57,313
$557,425
$709,402
Short-term debt
$0
$0
$0
$23,514
Long-term debt
$0
$375,000
$1,168,878
$1,282,531
Total liabilities
$0
$375,000
$1,168,878
$1,306,045
Other
Headcount
—
4
—
15

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Cap table

Principal holders% as the filing states it, Apr 30, 2021

  • Barry Goldman26.5%of company
  • Charlie Walch21.6%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Rule 506(b) · Equity · Feb 2023Closed
Raised $17.6MInvestors 12
Rule 506(b) · Equity · Sep 2021Closed
Raised $6.7MInvestors 38
Reg CF · Debt · Jan 2019Closedvia STL CRITICAL TECHNOLOGIES JV I, LLC
Raised $98K / $150K

Team

3 people
Barry GoldmanFounder
Science Advisor, Co-Founder
Charlie Walch
CEO
Glendon Schuster
CTO, Member, Board of Managers

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 8 annual reports (FY2018–FY2025)

38 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form DJun 2, 20230001759355-23-000001
    EDGAR
  • Form DOct 1, 20210001759355-21-000007
    EDGAR
  • Form C-ARApr 30, 20210001759355-21-000002
    EDGAR
  • Form C-UJun 10, 20190001759355-19-000010
    EDGAR
  • Form C/AMay 1, 20190001759355-19-000009
    EDGAR
  • Form C/AJan 10, 20190001759355-19-000008
    EDGAR
  • Form CJan 4, 20190001759355-19-000006
    EDGAR
  • Form DJan 2, 20190001759355-19-000001
    EDGAR
Source: SEC EDGARCIK 0001759355DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.